Actively Recruiting
Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis
Led by Assistance Publique Hopitaux De Marseille · Updated on 2024-08-01
500
Participants Needed
1
Research Sites
183 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Methodology This is a single-center study carried out as part of routine patient care. The aim of the study is to determine the performance of the 2nd generation TB-IGRA test in the diagnosis of tuberculosis.
CONDITIONS
Official Title
Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individual at least 18 years of age
- Patient presenting for treatment of tuberculosis disease
- Having undergone or benefiting from screening for tuberculosis using a medically prescribed reference IGRA test
- Informed patient who has not expressed opposition to participating in the study
- French-speaking patient with unambiguous understanding of oral and written instructions
You will not qualify if you...
- Persons currently excluded from another study
- Pregnant, parturient, or breast-feeding women
- Persons deprived of liberty by judicial or administrative decision
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Assistance Publique Hopitaux de Marseille
Marseille, France
Actively Recruiting
Research Team
P
PR PIERRE EDOUARD FOURNIER PU-PH
CONTACT
A
ALEXANDRA GIULIANI PROJECT MANAGER
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here